ライフサイエンスコーパス: surgical resection

1 was performed preoperatively and during the surgical resection.

2 iotherapy, stereotactic radiosurgery, and/or surgical resection.

3 with advanced imaging, possibly followed by surgical resection.

4 tidisciplinary cancer conference recommended surgical resection.

5 r RCT did not increase the rate of pCR after surgical resection.

6 ly of a selective tumor-specific approach to surgical resection.

7 (BOLD) change in the TL overlapping with the surgical resection.

8 predictor of DFS and OS in PHC patients with surgical resection.

9 r expansion, and on liver regeneration after surgical resection.

10 es are designed to prevent recurrences after surgical resection.

11 ctory to systemic therapy and ineligible for surgical resection.

12 y of Anesthesiology score, and the extent of surgical resection.

13 /or endoscopic relapse of CD in adults after surgical resection.

14 on of local lung cancer recurrence following surgical resection.

15 ho receive chemotherapy first and proceed to surgical resection.

16 (< and >/= 65 years old), KPS, and extent of surgical resection.

17 cations for the current quality criteria for surgical resection.

18 Before 1970, treatment primarily included surgical resection.

19 course of erlotinib monotherapy followed by surgical resection.

20 rasound-guided biopsy or mediastinoscopy) or surgical resection.

21 associated with shorter survival times after surgical resection.

22 Ninety-seven NF-PNET patients underwent surgical resection.

23 gan oligometastatic disease may benefit from surgical resection.

24 ter radiotherapy similar to those seen after surgical resection.

25 ct tumors, NIRF imaging enables image-guided surgical resection.

26 r (N = 40), and their levels decreased after surgical resection.

27 ich was compared with pathologic stage after surgical resection.

28 n before orthotopic liver transplantation or surgical resection.

29 ue in the preoperative clinic and throughout surgical resection.

30 ne defects attributed to trauma, disease, or surgical resection.

31 as a valid and less invasive alternative to surgical resection.

32 ration as candidates for tumor detection and surgical resection.

33 ally involves trans-arterial embolization or surgical resection.

34 the tumor is still localized and amenable to surgical resection.

35 04 and 2008, of whom 12,862 (9.6%) underwent surgical resection.

36 as these patients require extensive thoracic surgical resection.

37 doscopy and intraoperative image guidance of surgical resection.

38 n invasive procedure, for example, biopsy or surgical resection.

39 in a beneficial effect similar to that from surgical resection.

40 d most from the HP, especially subjects with surgical resection.

41 nostic for relapse-free survival (RFS) after surgical resection.

42 the potential in guiding minimally invasive surgical resection.

43 There were 659 patients (1.9%) underwent surgical resection.

44 r expansion, and on liver regeneration after surgical resection.

45 fuse growth pattern, which prevents complete surgical resection.

46 DAC progression and metastatic relapse after surgical resection.

47 enrolled less than 10 patients, or included surgical resection.

48 e tumor-free survival of patients undergoing surgical resection.

49 hed germline DNA from 27 patients undergoing surgical resection.

50 obtained from each of these sites during the surgical resection.

51 ted with higher morbidity and more difficult surgical resection.

52 serve as a screening tool and help to guide surgical resections.

53 s controls and CP samples were obtained from surgical resections.

54 or IIIA disease who have undergone complete surgical resections.

55 A total of 240 patients underwent surgical resection (152 at the time of diagnosis and 88

56 entified: 1) access flap and debridement; 2) surgical resection; 3) application of bone grafting mate

57 lostomy-free survival than did those who had surgical resection (74% [95% CI 64-82] vs 47% [37-57]; h

58 rvival were noted between watch and wait and surgical resection (88% [95% CI 75-94] with watch and wa

59 or more days) from the completion of CRT to surgical resection, adjusted for clinical stage, demogra

60 common childhood liver cancer is cured with surgical resection after chemotherapy or with liver tran

61 underwent radiotherapy or chemoradiotherapy, surgical resection after FOLFIRINOX, and R0 resection.

62 gically proven PADC who underwent pancreatic surgical resection aimed at removal of the primary tumor

63 ssue from 304 patients with HCC treated with surgical resection allowed us to generate a methylation-

64 esistant epilepsy syndrome of early life.(1) Surgical resection allows limited access to the small de

65 Patients with pT1-2N0M0 SCLC treated with surgical resection alone have worse outcomes than those

66 Surgical resection alone results in 45% recurrence and i

67 s with LPHL may be spared chemotherapy after surgical resection alone.

68 e to local recurrence compared with that for surgical resection alone.

69 , as well as 20 breast cancer patients after surgical resection and 10 female lung or colorectal canc

70 rosis, and improves organ function following surgical resection and chemical injuries.

71 central analysis, and had undergone maximal surgical resection and completion of standard chemoradia

72 ocation within the brain, are unsuitable for surgical resection and consequently have a universally d

73 e obtained from 50 patients with PDAC before surgical resection and filtered using the Isolation by S

74 ion of epithelial ovarian cancer (EOC) after surgical resection and first-line chemotherapy, about 60

75 lications and early relapse are common after surgical resection and immunomodulatory drugs can mainta

76 atic ductal adenocarcinoma (PDAC) allows for surgical resection and increases patient survival times.

77 int is critical for improving the success of surgical resection and increasing 5-year survival rates.

78 Local therapy with surgical resection and perhaps radiation therapy is used

79 Patients who underwent surgical resection and postoperative systemic chemothera

80 plications for individualizing the extent of surgical resection and radiation therapy volumes.

81 HCCs were collected from 17 patients during surgical resection and single-cell suspensions were anal

82 that fails to stop liver regeneration after surgical resections and elucidate mechanisms that are in

83 4, who underwent neoadjuvant chemoradiation, surgical resection, and adjuvant therapy.

84 Patients underwent surgical resection, and tumor samples underwent immunohi

85 by treatment with anticonvulsant medication, surgical resection, and/or nerve/brain electrode stimula

86 luN2C expression is upregulated in TSC human surgical resections, and a GluN2C/D antagonist reduces p

87 For OCSCC, 85% of the surgical resections appear inadequate.

88 negative Hopkins score both in those who had surgical resection as part of the primary treatment (HR

89 Seventeen patients underwent a surgical resection as the primary modality or as part of

90 evice demonstrated robust potential to guide surgical resections, as all peak tumor-to-background rat

91 atment should be initiated within 8 weeks of surgical resection, assuming complete recovery.

92 cancer centre cohort, 228 of whom underwent surgical resection at referring hospitals and 31 of whom

93 III colorectal tumors with MSI who underwent surgical resection at tertiary medical centers for HSP11

94 uct IPMN and removing the recommendation for surgical resection based on size alone.

95 in tumors present significant challenges for surgical resection because of their location and the fre

96 de survey, 14,872 patients of HCC treated by surgical resection between 2000 and 2005 were enrolled.

97 astatic colorectal adenocarcinoma undergoing surgical resection between 2006 and 2011 were included.

98 ients diagnosed with CRC undergoing elective surgical resection between 2006 and 2013 were included.

99 not only improve cancer detection and guide surgical resections, but also improve our understanding

100 Surgical resection can be undertaken through multiple ap

101 Results for 73 biopsies from 10 surgical resection cases show that DESI-MS allows detect

102 Patients were primarily treated with surgical resection, chemotherapy, radiation therapy, or

103 eased survival in hospitals performing > 150 surgical resections compared with those carrying out < 7

104 rototype work flow to whole sections, paired surgical resection/core needle biopsy samples, and paire

105 atient-specific factors, including extent of surgical resection (EOR).

106 en aggressive therapeutic approaches such as surgical resection followed by chemotherapy and radiothe

107 t therapy consists of maximal well tolerated surgical resection followed by combined radiotherapy and

108 Standard of care consists of surgical resection followed by radiotherapy and concomit

109 Current therapeutic strategies include surgical resection, followed by radiotherapy and chemoth

110 rt study included 103 patients who underwent surgical resection for a preoperative diagnosis of MD or

111 irteen individuals with FPC (6.1%) underwent surgical resection for a suspected PRL, but only four (1

112 ital gastrointestinal disorder that requires surgical resection for correction.

113 y squamous cell carcinoma undergoing upfront surgical resection for curative intent were identified i

114 so predicts fewer LNs being identified after surgical resection for EC.

115 We conclude that the literature on surgical resection for HGGs is influenced by medical aca

116 ectively reviewed 272 patients who underwent surgical resection for histologically confirmed IPMN fro

117 The proportion of patients who underwent surgical resection for locally advanced pancreatic cance

118 Two CDKN2A mutation carriers (1%) underwent surgical resection for low-risk PRL.

119 Surgical resection for medication-resistant and well-loc

120 Disparities in the utilization of surgical resection for patients with early-stage, resect

121 al classification of 283 patients undergoing surgical resection for stage I lung adenocarcinoma was d

122 s of FOLFOX4 or FOLFOX4 plus cetuximab after surgical resection for stage III colon cancer.

123 cohort study included patients who underwent surgical resection for stage III or IV distal oesophagea

124 ot sufficient to reliably diagnose BD-IPMNs, surgical resection for suspected small branch-duct IPMN

125 tricturing lesions, penetrating lesions, and surgical resection, for measuring disease progression.

126 atients with localized disease who underwent surgical resection formed the study population, and thei

127 cancer specimens from patients who underwent surgical resection from 2002 through 2008.

128 d HCC samples from 59 patients who underwent surgical resection from November 2013 through May 2017,

129 all cell lung cancer (NSCLC) not amenable to surgical resection has a high mortality rate, due to the

130 Surgical resection has a potential benefit for patients

131 Although surgical resection has been the mainstay of therapy for

132 nt predictor of short overall survival after surgical resection (hazard ratio 3.21, 95% CI 1.78-5.78)

133 factor for very early recurrence (<1 y after surgical resection) (hazard ratio, 1.7; 95% confidence i

134 After surgical resection, HP treatment response, perineural in

135 ve a complete clinical response were offered surgical resection if eligible.

136 cycles of neoadjuvant FLOT and proceeded to surgical resection if restaging (using computed tomograp

137 ltrate the brain, making complete removal by surgical resection impossible.

138 present analysis, we examine whether upfront surgical resection improves overall survival in a large

139 lete removal of residual tumor tissue during surgical resection improves patient outcomes.

140 lmFG activity through stimulation, and later surgical resection in one of the patients, led to impair

141 ges were supported for the use of endoscopic surgical resection in patients with limited disease (T1,

142 t and to identify predictors of the need for surgical resection in the subgroup of patients with stra

143 Surgical resection including regions of haemodynamic cha

144 ssary, the standard treatment is gross total surgical resection including the involved dura.

145 For patients with liver cancer, surgical resection is a principal treatment modality tha

146 Aggressive surgical resection is a successful approach in some pati

147 Surgical resection is appropriate in certain circumstanc

148 patients with limited disease and a complete surgical resection is associated with an inferior cancer

149 of 85 to 98 days between CRT completion and surgical resection is associated with significantly incr

150 Complete surgical resection is currently considered the only cura

151 Surgical resection is mandatory to prevent threatening m

152 ductal adenocarcinoma (PDAC) after complete surgical resection is often followed by distant metastat

153 Primary surgical resection is recommended for all patients who h

154 However, surgical resection is recommended for patients with an M

155 Surgical resection is regarded as the only potentially c

156 Although surgical resection is standard therapy, multiple observa

157 Surgical resection is standard treatment for patients wi

158 Surgical resection is the main curative option for gastr

159 Currently, surgical resection is the most effective way to manage s

160 Surgical resection is the only curative treatment for pa

161 Surgical resection is the standard of care for MPNSTs, b

162 For this type of tumor, surgical resection is the standard treatment of choice.

163 years (range 0.7-11.4), whereas compared to surgical resection it was 0.7 months at 3 years (range -

164 Typically observed at 2 y after surgical resection, late recurrence is a major challenge

165 or relapse included male sex, the absence of surgical resection, leukocyte counts >6.0 x 10(9)/L, and

166 Surgical resection, liver transplantation, and local abl

167 c tissue sections and prospectively evaluate surgical resection margins from pancreatic cancer surger

168 2 PET/CT was performed on 27 patients before surgical resection (median 4 d) of a renal mass.

169 A surgical resection model of ALF was used in 21 pigs.

170 sequenced primary tumour types obtained from surgical resections, much less comprehensive molecular a

171 6) and was limited to patients who underwent surgical resection (n = 47,302 excluded).

172 tive CECTs of 157 HCC patients who underwent surgical resection (N = 72) or LT (N = 85) between 2000

173 with a complete radiological response after surgical resection (n=900) or local ablation (n=214) in

174 Nomograms to predict RFS and OS after surgical resection of ACC were proposed using a multi-in

175 Surgical resection of asymptomatic IPT is controversial.

176 ave influenced strategies and thresholds for surgical resection of BAV aortopathy.

177 en 1984 and 2013, 248 patients who underwent surgical resection of BCA or BCAC were identified.

178 rast have the potential to molecularly guide surgical resection of cancer by extending whole-body dia

179 heir potential clinical use as an adjunct to surgical resection of cancers.

180 lysis for indeterminate nodules; options for surgical resection of CT-identified nodules; screening i

181 tal tissues to selectively avoid them during surgical resection of diseased tissue is of great signif

182 brain tissue from 33 children who underwent surgical resection of dysplastic cortex for the treatmen

183 ts and harms of these screening tests and of surgical resection of early-stage non-small cell lung ca

184 A total of 804 patients who underwent surgical resection of gastric adenocarcinoma were identi

185 The risk of recurrence following surgical resection of GISTs is typically reported from t

186 ed protoporphyrin IX (PpIX) for image-guided surgical resection of high-grade brain tumors (glioblast

187 iveness of the use of amino acid PET for the surgical resection of high-grade gliomas, compared with

188 Five patients awaiting surgical resection of histologically proven or radiologi

189 Surgical resection of ICC at a participating hospital.

190 improve the survival rate of patients after surgical resection of large amounts of liver tissue.

191 Surgical resection of larger tumors was associated with

192 As the role of optimal surgical resection of LM is widely accepted, our results

193 ents who receive radiation therapy following surgical resection of MCC may be a result of selection b

194 Patients with incomplete surgical resection of medulloblastoma are controversiall

195 aluate the survival benefit achieved through surgical resection of melanoma metastatic to the abdomin

196 Of 201 patients managed without surgical resection of metastases, 83 (41%), 89 (44%), an

197 International Consensus Guidelines recommend surgical resection of MPD-involved IPMN in fit patients.

198 r marker levels, radiology, and pathology at surgical resection of residual disease.

199 This should be followed by surgical resection of residual tumor in nonseminomatous

200 val and distant metastases in patients after surgical resection of soft-tissue sarcoma of the extremi

201 ontouring of the eyelid margin component and surgical resection of the anterior lamellar portion may

202 l reorganization of functional connectivity, surgical resection of the epileptic hippocampus offers a

203 ith pharmacoresistant focal epilepsy in whom surgical resection of the epileptogenic focus fails or w

204 The patient underwent surgical resection of the left upper lobe.

205 A highly invasive surgical resection of the liver tumor is the main approa

206 es after resection of the primary tumor, and surgical resection of the metastases offers the only opp

207 Surgical resection of the most destroyed sections of the

208 e only potentially curative treatment is the surgical resection of the primary tumor and hepatic lesi

209 tissue, allowing them to evade removal upon surgical resection of the primary tumor.

210 ith cisplatin-based chemotherapy followed by surgical resection of the residual tumor.

211 Patients underwent surgical resection of the target lesions, and tissues we

212 Surgical resection of the temporal lobe is an effective

213 rd of care for head and neck cancer includes surgical resection of the tumor followed by targeted hea

214 mpetent hosts improved animal survival after surgical resection of the tumors, by suppression of tumo

215 TNM staging system and is the rationale for surgical resection of tumor-draining lymph nodes.

216 Surgical resection of tumors with negative margins is th

217 CTCs in pulmonary vein blood accessed during surgical resection of tumors.

218 frared fluorescence imaging and image-guided surgical resection of U87MG tumors.

219 Surgical resections of CRC LM were identified from hospi

220 ET and SPECT provide crucial data that guide surgical resections of the epileptogenic zone for medica

221 er transplantation only and those undergoing surgical resection only were highest in the terminal pha

222 chemotherapy, and a better understanding of surgical resection options forming the foundation for th

223 HGD of the esophagus may be managed by surgical resection or EMR-RFA.

224 of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxi

225 patients, particularly those ineligible for surgical resection or liver transplant.

226 ent predictor of poor outcomes subsequent to surgical resection or liver transplantation (LT); howeve

227 patients with hepatocellular carcinoma after surgical resection or local ablation.

228 giocarcinoma (Klatskin tumors) is limited to surgical resection or orthotopic liver transplantation.

229 n, infiltrative BCC that was not amenable to surgical resection or radiation.

230 atients with brain metastases unsuitable for surgical resection or stereotactic radiotherapy were ran

231 Whole sections of surgical resections or tissue microarrays (TMAs) from in

232 s were obtained from an endoscopic biopsy or surgical resections performed at Johns Hopkins Hospital.

233 ship between tumor and the low rectal cancer surgical resection plane (mrLRP).

234 Achievement of complete surgical resection plays a key role in successful treatm

235 Surgical resection plus adjuvant platinum-based chemothe

236 The surgical resection procedures such as the radical pancre

237 Surgical resection provides better long-term OS and RFS

238 malignant brain tumor, and is refractory to surgical resection, radiation, and chemotherapy.

239 al prognoses due to limited effectiveness of surgical resection, radiation, and chemotherapy.

240 brain tumor in children, remains limited to surgical resection, radiation, and traditional chemother

241 r study, the current recommendation is still surgical resection regardless of the posttherapy PET SUV

242 ors associated with long-term outcomes after surgical resection remain poorly defined.

243 inal melanoma metastases, demonstrating that surgical resection remains an important treatment consid

244 Surgical resection remains the cornerstone of management

245 Surgical resection remains the cornerstone of therapy fo

246 Although surgical resection remains the primary treatment modalit

247 r surgery prediction by performing in silico surgical resections, removing nodes from patient network

248 treatment in some sub-types warrants radical surgical resections resulting in high morbidity.

249 s have increased the rate of curative-intent surgical resections, resulting in median survival in thi

250 Surgical resection should be considered as the first-lin

251 Surgical resection should be considered in diagnostic al

252 Surgical resection should be reserved for large or sympt

253 Although maximum safe surgical resection should remain the standard of care, s

254 Brain tissue surrounding surgical resection site can be injured inadvertently due

255 hich leads to patients undergoing aggressive surgical resections, so-called second-look surgeries, an

256 We evaluated the histology in the surgical resection specimens and compared clinicopatholo

257 Intestinal crypts were obtained from surgical resection specimens of 7 individuals without in

258 ter of tumor and 5 cm from tumor margin from surgical resection specimens.

259 clinical complete response and those who had surgical resection (standard care).

260 Mortality risk for major gastrointestinal surgical resections starts increasing at 50 years of age

261 from melanoma is controversial and includes surgical resection, stereotactic radiosurgery (SRS), and

262 After surgical resection, strain of full gut wall segments was

263 ough bottlenecks, but re-grow by the time of surgical resection, suggesting a missed therapeutic oppo

264 basal-cell carcinomas that were eligible for surgical resection (surgically eligible) with vismodegib

265 -94] with watch and wait vs 78% [63-87] with surgical resection; time-varying p=0.043).

266 Archival surgical resection tissue contained RNA foci, dipeptide

267 tment paradigm has been shifted from radical surgical resection to an organ-preservation approach.

268 ts were studied twice before and ~6 wk after surgical resection to assess muscle protein synthesis (M

269 asing age or because of cellular stress (eg, surgical resection, toxic exposure, or viral infections)

270 cular invasion, resection margin status, and surgical resection type.

271 oscopic or surgical) was compared with major surgical resection using adjusted hazard ratios (HRs) fo

272 -one paired cohorts of watch and wait versus surgical resection using propensity-score matching (incl

273 all cases, the tumor was managed by primary surgical resection using wide excisional biopsy, limited

274 HPV-negative OPSCC when treated with primary surgical resection vs CRT.

275 Primary surgical resection vs definitive CRT.

276 The mean duration of epilepsy before surgical resection was 20.1 years among adults and 5.3 y

277 GG, treatment at a center that favored early surgical resection was associated with better overall su

278 Surgical resection was based on tumor site and accessibi

279 ic survival among the patients who underwent surgical resection was independently associated with geo

280 Surgical resection was independently associated with les

281 The extent of surgical resection was influenced by synchronous colonic

282 herapy-naive NSCLC patients for whom primary surgical resection was planned.

283 Surgical resection was significantly associated with bet

284 Complete surgical resection was subsequently performed and histop

285 Only patients who underwent surgical resection were considered (n = 170).

286 with non-small cell lung cancer eligible for surgical resection were enrolled in this study.

287 ed neoadjuvant chemoradiotherapy followed by surgical resection were included.

288 or and tumor bed from 50 patients undergoing surgical resections were subject to DESI MSI.

289 el plus 41.4 Gy concurrent radiotherapy) and surgical resection, were analyzed.

290 ated colonic diverticulitis usually requires surgical resection, which is associated with significant

291 c agents to the glioma cells remaining after surgical resection while sparing normal healthy brain ce

292 Surgical resection with microscopically negative margins

293 For many tumors, primary treatment is surgical resection with negative margins, which correspo

294 commended; if the BMs are greater than 4 cm, surgical resection with or without postoperative whole-b

295 hn disease who had strictures that underwent surgical resection with pathologic confirmation.

296 rrelated the network damage score (caused by surgical resection) with postsurgical brain function, an

297 f oncological factors indicating an adequate surgical resection, with a noninferiority boundary of De

298 Most patients require surgical resection, with prior reduction done in selecte

299 Failed cases often require surgical resection, with risks for epithelial downgrowth

300 andardized 3-drug preoperative chemotherapy, surgical resection within 12 weeks of diagnosis and resp